Keywords

deep vein thrombosis, direct-acting oral anticoagulants, direct oral anticoagulants, DOACs, drug-drug interactions, DVT, periprocedural management, phase of treatment, provoked VTE, reversal strategies, thromboembolic risk factors, unprovoked VTE, venous thromboembolism, VTE

Authors

1. Thanavaro, Joanne L. DNP, APRN, AGPCNP-BC, AGACNP-BC, DCC, FAANP

Abstract

Abstract: Direct oral anticoagulants (DOACs) are effective for both prevention and treatment of venous thromboembolism (VTE) and have favorable safety in comparison with warfarin. Although drug-drug interactions with DOACs are not as frequent as with warfarin, certain drugs can interfere with DOAC metabolism, affect DOAC efficacy, and potentially cause adverse reactions when used in combination with DOACs. The NP must determine which agent is most beneficial for the individual patient with VTE based on a number of factors. A knowledge of periprocedural management of DOACs will assist the NP in providing a smooth transition for patients undergoing minor and major procedures and surgeries.